- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00327847
Optimizing Vitamin D Nutrition in Healthy Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is ample evidence that improvement in vitamin D nutrition retards bone loss and prevents fractures in the elderly. It is clear that many people living in areas of northern latitude have less than optimal levels of vitamin D. The current recommendations for vitamin D intake are not enough to bring a large majority of the population to the desired adequate level. Furthermore, differences have been observed in the amount of Vitamin D produced in the skin in whites and blacks.
Based on the evidence from literature and our experience from prior studies we hypothesize that:
- the dose of oral vitamin D3 supplement exceeds current recommendations to achieve adequate desired level;
- there may be differences in the dose-response to vitamin D supplement between Blacks and Whites; and
- vitamin D supplementation that produces serum 25-hydroxyvitamin D (25-OHD) levels in the range proposed is safe.
The aims for this pilot study are to determine:
- the average dose of vitamin D3 needed to attain 25-OHD levels between 80-140 nmol/L in a healthy population of mixed races; and
- if there are differences in response to vitamin D3 supplementation between African American and Caucasians subjects.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Mineola, New York, United States, 11501
- Winthrop University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy African-American and Caucasian adults aged 18-65 years.
Exclusion Criteria:
- Subjects who are not either African-American or Caucasian. The investigators plan to examine racial differences in response to oral vitamin D dosing and, therefore, have chosen the most affected (African-American) and the least affected (Caucasian) racial groups. Including other racial/ethnic groups may confound the results unless they are studied as separate groups.
- Any chronic medical illness including diabetes mellitus, history of myocardial infarction or heart failure, malignancy, hypertension (systolic blood pressure [SBP] > 140), obesity (body mass index [BMI] > 35 kg/m2), history of anemia, leukemia, or other hematologic abnormalities, lupus, rheumatoid arthritis, or other rheumatologic disease, or kidney disease of any kind as determined by history and physical examination.
- Subjects with osteoporosis or taking medications for osteoporosis such as bisphosphonates.
- Pregnancy.
- Use of medication that influences bone metabolism (i.e. anticonvulsant medications, steroids, diuretics).
- Significant deviation from normal in either history, physical examination, or laboratory tests, as evaluated by the primary investigator.
- Patients with a history of hypercalciuria, hypercalcemia, nephrolithiasis, and active sarcoidosis.
- Participation in another investigational trial in the past 30 days prior to the screening evaluation.
- Unexplained weight loss of > 15% during the previous year or history of anorexia nervosa.
- Medications that interfere with vitamin D metabolism. Oral contraceptive use will be allowed, but will be appropriately documented.
- Smokers greater than 1 pack per day.
- Patients reporting alcohol intake greater than 2 drinks daily.
- Subjects with baseline 25-OHD level greater than 80 nmol/L or less than 20 nmol/L.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John F. Aloia, M.D., Winthrop University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB Protocol #04037
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
-
Okan UniversityArçelik A.Ş.Completed
-
Brigham and Women's HospitalCompletedVitamin d Deficiency
Clinical Trials on Oral Vitamin D Supplementation
-
Shenzhen Center for Chronic Disease ControlDanone Institute China Diet Nutrition Research and CommunicationCompleted
-
IIMC, Riphah International University, PakistanNot yet recruitingGestational Diabetes MellitusPakistan
-
University of Alabama at BirminghamRecruitingPrematurity; ExtremeUnited States
-
Medical University of BialystokLomza State University of Applied Sciences; International Science & Health... and other collaboratorsRecruitingVitamin D3 | Fracture Healing | Deficiency of Vitamin K2Poland
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
CHU de Quebec-Universite LavalKhlôros Technology; Anne-Sophie MorissetCompleted
-
Princess Anna Mazowiecka Hospital, Warsaw, PolandMedical University of WarsawCompletedNephrolithiasis | Vitamin D Deficiency | Osteopenia | Drug OverdosePoland
-
University of the PunjabCompletedMaternal and Child HealthPakistan
-
The Cooper Health SystemWon Sook Chung FoundationCompletedRespiratory Tract Infections | Covid19 | Flu Like IllnessUnited States
-
Lebanese American UniversityCompletedVitamin D Deficiency | Depressive SymptomsSaudi Arabia